Study of peptide mimetics of hepatitis A virus conjugated to keyhole limpet hemocyanin and as multiple antigen peptide system

Aguilar, A. et al. (2014) Study of peptide mimetics of hepatitis A virus conjugated to keyhole limpet hemocyanin and as multiple antigen peptide system. International Journal of Peptide Research and Therapeutics, 20(1), pp. 33-42. (doi: 10.1007/s10989-013-9364-x)

Full text not currently available from Enlighten.

Publisher's URL:


Mimotopes mimic binding properties of natural antigen epitopes. They could be used for vaccine design, drugs development, and diagnostic assays. We have previously identified four bacteriophages displaying hepatitis A virus (HAV) mimotopes from a phage-display peptide library by affinity selection on serum antibodies from hepatitis A patients. Three of these HAV mimotopes showed similarity in their amino acid sequences with at least one of the VP3 and VP1 antigenic proteins of HAV and the four induced specific anti-HAV antibodies. In the present work, four conjugations were done. In each of them, a linear peptide (46, 53, 54 or 56) containing the amino-acid sequence of the corresponding mimotope was conjugated to keyhole limpet hemocyanin (KLH). Conjugation products were named: 46KLH, 53KLH, 54KLH and 56KLH. A two-arm multiple antigen peptide (MAP) system containing peptide sequence 46, and a second MAP containing two copies of peptide sequence 56 were synthesized and dimerized, to obtain the heterodimeric four-arms MAP (named MAP46-56) containing two copies of peptides 46 and 56. Mice were immunized with peptides conjugated to KLH and MAP46-56 to evaluate the ability of these two forms of mimotope presentation, to elicit antibodies that bind to the original antigen. KLH conjugated peptides rendered the highest levels of anti-peptide antibodies and were the only ones that induced specific anti-HAV antibodies. The results of immunizations showed that for the mimotopes chosen here, conjugation to a carrier protein was the most effective option to induce antibodies that cross-reacted with the natural antigen.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Stott I, Professor David
Authors: Aguilar, A., Camacho, F., Martínez, R., Huerta, V., Garay, H. E., Amin, N., Talavera, A., Fariñas, M., Reyes, O., Stott, D. I., Acosta, A., and Pérez, E. M.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:International Journal of Peptide Research and Therapeutics
ISSN (Online):1573-3904

University Staff: Request a correction | Enlighten Editors: Update this record